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Cys-loop receptors are ligand-gated ion channels that are activated by a structurally diverse
array of neurotransmitters, including acetylcholine, serotonin, glycine, and GABA. After the
term “chemoreceptor” emerged over 100 years ago, there was some wait until affinity
labeling, molecular cloning, functional studies, and X-ray crystallography experiments
identified the extracellular interface of adjacent subunits as the principal site of agonist
binding. The question of how subtle differences at and around agonist-binding sites
of different Cys-loop receptors can accommodate transmitters as chemically diverse as
glycine and serotonin has been subject to intense research over the last three decades.
This review outlines the functional diversity and current structural understanding of
agonist-binding sites, including those of invertebrate Cys-loop receptors. Together, this
provides a framework to understand the atomic determinants involved in how these
valuable therapeutic targets recognize and bind their ligands.
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DIVERSITY, PHYSIOLOGICAL IMPORTANCE, AND
FUNDAMENTAL ARCHITECTURE
Numerous physiological processes rely on the rapid conversion
of extracellular chemical signals into electrical signals at the cell
membrane. This is predominantly mediated by ligand-gated ion
channels (LGICs), membrane-embedded ion channels that are
allosterically activated upon binding of an agonist, usually a neu-
rotransmitter. A large family of LGICs is that of the pentameric
Cys-loop receptors, sometimes referred to as pentameric ligand-
gated ion channels, as not all members of this protein family
contain the eponymous Cys-loop. These receptors are broadly
divided into excitatory and inhibitory receptors, based on the
permeability of the integral ion channel to cations or anions,
respectively. As regards the human nervous system, passage of
sodium and calcium through excitatory nicotinic acetylcholine,
and serotonin type 3 receptors (nAChRs and 5-HT3Rs) depo-
larizes the membrane, whereas chloride permeability through
inhibitory GABA type A and glycine receptors (GABAARs and
GlyRs) generally serves to hyperpolarize the membrane potential
and thereby decrease cellular excitability. Activation of nAChRs
by acetylcholine mediates vital neuromuscular and autonomic
signals (Langley, 1901; Bennett, 2000) and the importance of
nAChRs in the brain is highlighted by the well-documented
effects of nicotine on cognition (Levin, 2002). 5-HT3Rs medi-
ate several effects of serotonin on maturation of glutamatergic
and GABAergic networks (Engel et al., 2013) and are targets
for widely used anti-emetic drugs (Lummis, 2012). Humans
also express transcripts of a unique Cys-loop receptor isoform
that, when expressed recombinantly, forms zinc-activated cation
channels, although little is known about its function (Davies
et al., 2003). Regarding the inhibitory receptors, some over-
lap occurs in the expression patterns of GABAARs and GlyRs.
GABAARs are the primary mediator of inhibitory signals in
the brain (Sigel and Steinmann, 2012), and pharmacological
enhancement of GABAARs by benzodiazepines and anesthetics
underlies widely used anxiolytic therapies (Korpi and Sinkkonen,
2006) and general anesthesia (Zeller et al., 2008), respectively.
Inhibitory GlyR function, on the other hand, appears to dom-
inate in the spinal cord and brain stem, regulating different
motor and sensory functions, including pain, and GlyRs are
also involved in processing auditory and visual signals (Lynch,
2009).
Each of the above receptors is further divided into subtyes,
composed of varying combinations of different subunit isoforms.
In humans, there are five known GlyR isoforms (α1 through α4
and β; Harvey et al., 2000) and five 5-HT3R isoforms (named
A to E; Lummis, 2012). By contrast, nAChR and GABAAR iso-
forms show a far greater degree of diversity: 17 different isoforms
are known for nAChRs [nine α (termed α1, α2, α3, and so
on), four β, one γ, one δ, and one ε isoforms] and 19 differ-
ent isoforms for GABAARs (six α, three β, three γ, one each
of δ, ε, π, θ, and three ρ isoforms; Collingridge et al., 2009).
Although some subtypes are homomeric pentamers, the major-
ity of native Cys-loop receptors are heteromers. Together with
the significant isoform diversity, this results in a large number of
possible permutations (although the most prominent stoichiom-
etry in the brain is 2xα1, 2xβ2, and 1xγ2; Olsen and Sieghart,
2008).
However, the true diversity of the Cys-loop receptor fam-
ily is only realized when invertebrate and bacterial members
are considered. These include, in addition to nAChR-like and
GABAAR-like receptors, cation channels gated by betaine (Peden
et al., 2013), GABA (Ranganathan et al., 2000) primary amines
(Zimmermann and Dutzler, 2011), and pH (Bocquet et al., 2007);
anion channels gated by glutamate (Cully et al., 1994), histamine
(Zheng et al., 2002), dopamine, serotonin, tyromine (Ringstad
et al., 2009), and pH (Schnizler et al., 2005); and acetylcholine-
binding proteins (AChBPs) that resemble the extracellular half of
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nAChRs and serve to buffer excessive transmitter at the molluscan
synapse (Smit et al., 2001). Incidentally, it is lower organisms
that have contributed the Cys-loop receptors most amenable to
structural methods, and the resolution with which we now view
receptor structure is based on X-ray crystallographic structures of
two bacterial cation channels referred to as ELIC and GLIC (gated
by primary amines and protons, respectively; Hilf and Dutzler,
2008, 2009; Bocquet et al., 2009; Zimmermann and Dutzler, 2011;
Spurny et al., 2012), the α glutamate-gated chloride channel from
Caenorhabditis elegans (Hibbs and Gouaux, 2011; α GluCl, or
GLC-1; Beech et al., 2010) and AChBPs from Lymnaea stag-
nalis (Brejc et al., 2001) and Aplysia californica (Hansen et al.,
2005). These have superceded electron micrographic data on
nAChRs from the ray Torpedo marmorata (e.g., Unwin, 2005) that
consolidated early notions of receptor structure.
Collectively, the crystal structures confirm early biochemical
studies, in that Cys-loop receptors are pentamers in which each
subunit contains an extracellular domain (ECD), consisting of
10 consecutive strands arranged in two β-sheet cores, followed
by four membrane-spanning helices (M1–M4), ending in a small
extracellular C-terminal tail (Figure 1A). The agonist-binding
site is situated at the interface of adjacent ECDs (Figure 1B).
The principal face of the agonist-binding site comprises three
loops (“A–C”) from the outer β-sheet of one subunit, and the
complementary face comprises three β-strands and one loop
(“Loops D–G”) from the inner β-sheet of the adjacent subunit
(Figure 1C). The five subunits are arranged in five-fold symme-
try, such that a central ion channel is formed by the apposition
of all M2 helices. Opening of the ion channel occurs as a result
of agonist-induced conformational changes in the ECD, which
in turn trigger conformational changes within the ion channel,
in an allosteric process often termed ligand-gating or agonist-
induced activation (Twyman and Macdonald, 1991; Miller and
Smart, 2010). It is important to note that, depending on which
isoforms are present, not all subunits contribute equally to agonist
binding or subsequent channel gating, so the number of binding
sites can vary among different receptors. Some nAChRs have been
reported to open in response to a single bound agonist (Andersen
et al., 2013) or even in the absence of any ligands (Jackson, 1986;
Purohit and Auerbach, 2009). However, most Cys-loop receptors
are thought to require binding of 2–3 agonist molecules for most
efficient activation (Sine et al., 1990; Beato et al., 2002; Rayes et al.,
2009; Harpsoe et al., 2011).
Ligands that induce channel opening are termed agonists,
although some agonists induce channel opening with poor effi-
ciency and are therefore termed partial agonists. The five classical
neurotransmitter agonists considered in this review are shown
in Figure 2, illustrating their vaguely linear structure, with polar
N- or O-containing termini. Other ligands, termed competitive
antagonists, bind in the agonist-binding site and can elicit con-
formational changes but prevent binding of agonists and thus
channel activation. As this review focuses on the primary deter-
minants of ligand-receptor interactions at the agonist-binding
site, we will continuously refer to “recognition” of “agonists” for
consistency.
TRACING THE RECOGNITION OF DIVERSE AGONISTS TO
SUBTLE MOLECULAR DIFFERENCES
Below, the molecular determinants of agonist recognition by Cys-
loop receptors will be reviewed in detail, but given the diversity
of the family, generalizing detailed findings to the whole family
can be confusing. Therefore, we will first point out a few note-
worthy trends that we hope illustrate the relation between the
various Cys-loop receptors and also distinguish Cys-loop recep-
tors from other proteins. Given that certain Cys-loop receptors
are gated by glycine, while others are activated by the chemically
and structurally very different serotonin, there must naturally be
a substantial degree of divergence at critical agonist-binding side
chains in the agonist-binding site. Not surprisingly then, most
of the ECD side chains that are absolutely conserved lie outside
of the agonist-binding loops (Hibbs and Gouaux, 2011), e.g., in
the eponymous Cys-loop that is situated between the ECD and
the membrane-spanning domain, where it transduces conforma-
tional changes from the agonist-binding site to the channel (Kash
et al., 2003; Grutter et al., 2005). Only two side chains/motives
within agonist-binding loops are conserved across all Cys-loop
FIGURE 1 | Fundamental Cys-loop receptor architecture. (A) Pentameric
Cys-loop receptor, viewed from within the membrane (gray) plane. Each of
the five subunits is indicated by a different color and contains an extracellular
N-terminal extracellular domain (ECD) consisting of two β-sheets and a
membrane-spanning domain comprised of four α-helices. (B) Magnified view
of the interface of adjacent ECDs: one subunit in green, one in blue. The
outer β-sheet of the green and the inner β-sheet of the blue form the principal
and complementary faces, respectively, of the agonist-binding site. (C)
Magnified view of the agonist-binding site, showing agonist-binding loops
A–C of the principal face and D–G of the complementary face. All images are
based on the glutamate-bound Caenorhabditis elegans α GluCl crystal
structure, Protein DataBase reference 3RIF (Hibbs and Gouaux, 2011).
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receptors: a tryptophan in Loop D, and a Trp-X-Pro (“W-X-P”)
motif in Loop A (Figure 3), which at least in 5-HT3Rs is known
to contribute to structural integrity (Deane and Lummis, 2001).
Although not absolutely conserved, a handful of ECD positions
are occupied by structurally similar side chains in the vast major-
ity of Cys-loop receptor isoforms, including aromatic side chains
in Loop A, Loop B, and Loop C (Figure 3). These aromatic
side chains are widely acknowledged as an “aromatic box” that
FIGURE 2 | Conventional Cys-loop receptor agonists. Glycine, GABA, and
glutamate are neurotransmitters that bind to inhibitory receptors, while
serotonin and acetylcholine bind to excitatory receptors. Note the different
electrical state of these agonists under physiological conditions: glycine and
GABA are zwitterions, while acetylcholine and serotonin carry a single
positive charge and glutamate a net negative charge.
FIGURE 3 | Amino acid sequence alignment. Only side chains in
agonist-binding loops are shown, plus small segments abutting Loop A and
Loop B. Hum, human; Lym, Lymnaea stagnalis; Erw, Erwinia
chrysanthemi; Glo, Gloeobacter violaceus; Cae, Caenorhabditis elegans;
Dro, Drosophila melanogaster. ∗Refers to nAChR isoform 1, which is
up-regulated in muscle but less abundant in humans than isoform 2, which
contains a 25 amino acid insert in Loop D (Beeson et al., 1990; Talib et al.,
1993). While ELIC gates in response to primary amines, GLIC is a
proton-gated cation channel. HisCl 1 (Zheng et al., 2002), ACC-1 (Putrenko
et al., 2005), MOD-1 (Ranganathan et al., 2000), and LGC-55 (Ringstad
et al., 2009) are histamine, acetylcholine, serotonin, and tyromine-gated
chloride channels, respectively. Gray boxes indicate conserved aromatic
side chains A, B, C1 and C2. Arrows indicate the position of functionally
important side chains described in the main text, left-to-right: pre-Loop B
threonine in 5-HT3Rs; post-Loop B side chain in nAChRs; Loop C threonine
in GlyRs, GABAARs, and GluCls; Loop D aromatic side chain in nAChRs;
Loop D arginine/glutamine side chain in GluCls/AChBP; and Loop G
arginine in GluCls. Performed in ClustalW2 (Larkin et al., 2007).
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surrounds the amine or ammonium nitrogen atom of most Cys-
loop receptor agonists (Galzi et al., 1990; Zhong et al., 1998; Beene
et al., 2004; Pless et al., 2011; Lummis et al., 2012). To avoid confu-
sion when comparing numerous receptors, we will refer to these
aromatic side chains with the three-letter amino acid abbrevia-
tion followed by the letter of the possessing loop. For example,
Trp149 of the mouse α nAChR, Trp143 of the L. stagnalis AChBP
and Phe159 of the human α1 GlyR isoforms will be referred to as
TrpB, TrpB, and PheB, respectively.
When compared to a representative number of other proteins,
perhaps the most striking pattern to emerge from the amino acid
composition of Cys-loop receptor ECDs is the overrepresenta-
tion of aromatic side chains (Figure 4). Especially the relative
abundance of Tyr and Trp is strongly increased, which is likely
due to the manifold suitability of these side chains for molecular
recognition: these large amphipathic side chains can form non-
polar, H-bonding, and cation-π interactions (Koide and Sidhu,
2009). This is borne out in several experimental observations
that will be discussed below. Furthermore, it is noteworthy that
Arg is more prevalent than Lys, which is by far the most under-
represented of all 20 side chains in Cys-loop receptor binding
sites (Figure 4). A likely explanation for this observation is the
fact that Arg side chains retain their positive charge even in very
hydrophobic environments (Harms et al., 2011), whereas Lys side
chains undergo large pKa shifts depending on the dielectric of
their environment (Isom et al., 2011). The reliance of agonist
FIGURE 4 | Relative abundance of amino acids in Cys-loop receptor
agonist-binding loops. (A) Relative frequency (y-axis) at which each amino
acid (x-axis) appears in a set of 520 proteins (dark columns; Brooks et al.,
2002) and in the 25 Cys-loop receptor agonist-binding loops as shown in
Figure 3 (light columns). (B) Fold increase (positive numbers) or decrease
in frequency at which amino acids appear in Cys-loop receptor
agonist-binding loops compared to the general protein set.
recognition on Arg side chains is exemplified by the Loop D and
E Arg side chains of anion-selective Cys-loop receptors (see below
and Figure 3). Indeed, dividing receptor subtypes according to
their ion selectivity (i.e., according to their membrane-spanning
domains) reveals further patterns in the ECD. Viewed in this way,
the Loop A W-X-P motif is extended to a W-X-P-D-I/V motif
in cation-selective receptors such as nAChRs and 5-HT3Rs and
to W-X-P-D-T-F-F-X-N in most anion-selective receptor sub-
units (Figure 3). The crucial roles in agonist recognition of these
motifs, although subtly different in cation- and anion-selective
receptors, will be described below. At this point, we simply wish
to emphasize that amino acid sequence identity can provide clues
on agonist recognition. As observed by others, if chloride channel
isoforms that recognize diverse agonists group together in phylo-
genetic analyses, it is likely that the molecular changes that lead to
divergent agonist recognition are subtle and therefore identifiable
(Putrenko et al., 2005; Kehoe et al., 2009; Beech et al., 2013).
CHEMICAL AND STRUCTURAL INSIGHTS INTO AGONIST
RECOGNITION: EXCITATORY RECEPTORS
After the labeling of nAChRs with photo-reactive ligands iden-
tified the aromatic box (Dennis et al., 1988; Galzi et al., 1990),
the field began to address the exact arrangement of the bound
agonist and the nature of interactions that determine agonist
recognition (Dougherty and Stauffer, 1990). This has convention-
ally employed the alteration of receptor structure by site-directed
mutagenesis and the measure of function by electrophysiology
or by radioactive ligand binding. Such experiments have been
insightful, especially in the absence of high-resolution structures,
showing for example that in α(2)βγδ nAChRs, the TyrA and
TyrC1 hydroxyls, and the TyrC2 phenyl ring are important to
the recognition of quaternary ammonium agonists by α isoforms
(Tomaselli et al., 1991; O’Leary andWhite, 1992; Sine et al., 1994).
There was some wait until the X-ray crystallographic structures of
the Lymnaea stagnalis AChBP in complex with carbamylcholine
or nicotine provided a structural explanation for these findings
(Celie et al., 2004), showing on the one hand this highlighted the
proximity of TyrA and TyrC1 hydroxyls to the quaternary ammo-
nium (or other polar side chains) and, on the other hand, the
sandwiching of the quaternary ammonium by TrpB and TyrC2
phenyl rings (Figure 5A). Regarding the carbamyl terminal of the
agonist, the AChBP-carbamylcholine crystal structure shows the
carbamyl group some three to five Å from Loop E hydropho-
bic side chains and a highly conserved Loop D aromatic side
chain (tryptophan in AChBP; Figure 5A). Mutation of the loop D
tryptophan decreases agonist affinity for α7 nAChRs (Corringer
et al., 1995) and 5-HT3Rs (Spier and Lummis, 2000), and only
in α nAChR isoforms, which form exclusively principal agonist-
binding faces, is this side chain non-aromatic (Figure 3). Two
principals of agonist recognition that had remained obscured
from the conventional mutagenesis approach were elucidated by
this structural approach: the crystal structures suggested a hydro-
gen bond between the backbone carbonyl of TrpB—which cannot
be substituted using conventional site-directedmutagenesis—and
the nicotine pyrrolidine nitrogen; and a water-bridged hydrogen
bond between backbone carbonyls from Loop E and the nico-
tine pyridine nitrogen (Celie et al., 2004; nicotine binding is
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FIGURE 5 | X-ray crystallographic structures of agonist-bound receptors.
(A) L. stagnalis AChBP in complex with carbamylcholine (PDB entry 1UV6).
(B) C. elegans α GluCl (GLC-1) in complex with glutamate (and ivermectin in
the transmembrane domain; PDB entry 3RIF). In each illustration, numerous
segments have been removed for clarity, including Loop C, of which only
selected side chains are visible.
described in detail under Other Notable Agonists below). Agonist
recognition via backbone carbonyls and water molecules suggests
a tolerance for different side chains at functionally important
positions and goes some way to explaining the small number of
absolutely conserved ECD amino acids.
These functional and structural data collectively suggest, but
do not provide direct chemical evidence, for the types of interac-
tions that mediate agonist recognition. Such a “chemical-scale”
view of agonist recognition requires the insertion of artificial
amino acids (Dougherty, 2008). By exchanging single atoms or
functional groups of amino acids it is possible to dissect differ-
ent physico-chemical properties with atomic precision (Pless and
Ahern, 2013). Via substitution of α nAChR TrpB with Trp analogs
possessing a fluorinated indole ring, for example, it is possible
to progressively disperse π electrons from the face of the aro-
matic and incrementally impair binding to cations; this approach
identified a cation-π interaction between TrpB and the posi-
tively charged quaternary ammonium of acetylcholine (Zhong
et al., 1998). In the same way, cation-π interactions with TrpB
have also been shown for acetylcholine and nicotine in α4 nAChR
isoforms (Xiu et al., 2009; Puskar et al., 2011). However, this
interaction is not uniquely predicted by the presence of TrpB,
as in the closely-related muscle-type α nAChR isoforms, TrpB
does not form a cation-π interaction with nicotine (α nAChR iso-
forms lack an α4-like lysine side chain downstream of TrpB, which
effects Loop B/Loop C proximity and therefore the orientation
of TrpB Grutter et al., 2003; Xiu et al., 2009). Similarly, despite
the absolute requirement of TrpB in homomeric α7 nAChRs for
agonist recognition (Williams et al., 2009), it is only TyrA of the
α7 nAChR that forms a cation-π interaction with acetylcholine
(Puskar et al., 2011). Using unnatural amino acids, receptor
backbone carbonyls are also amenable to modification. In α4-
containing nAChRs, the replacement of the subsequent amino
acid with its α-hydroxyl analog substitutes the α4 nAChR TrpB
backbone carbonyl for a hydroxyl, a poorer H-bond acceptor,
and selectively reduces nicotine affinity (Xiu et al., 2009). This
is consistent with the H-bond suggested by structural data and
homology modeling (Celie et al., 2004; Talley et al., 2006). Finally,
a conserved aspartate in Loop A was initially assigned an indirect
role in agonist recognition as an acceptor of H-bonds with back-
bone amides of Loop B (Celie et al., 2004; Lee and Sine, 2004); a
subsequent study using unnatural neutral Asp derivatives in Loop
A and α-hydroxyl amino acids in Loop B instead pointed to a
redundant network of hydrogen bonds that does not necessarily
require H-bond accepting at this Loop A position (Cashin et al.,
2007).
The binding of serotonin in the 5-HT3R ECD is similar to
that of acetylcholine in the nAChR, in that the amine nitro-
gen of serotonin forms a cation-π interaction with TrpB (Beene
et al., 2002) and the polar 5-hydroxyl is likely oriented toward
the complementary face, according to mutagenesis and homol-
ogy modeling (Beene et al., 2004). This arrangement is supported
by the crystal structure of a serotonin-bound Aplysia californica
AChBP with substitutions for 5-HT3R-equivalent amino acids
that enhance serotonin binding (Kesters et al., 2013). This struc-
ture also shows proximity of the amine nitrogen to the TyrA
hydroxyl (asparagine in 5-HT3R) and to the TyrC2 phenyl ring
(conserved in AChBP and 5-HT3R), consistent with the direct but
distinct role of these tyrosine side chains implied by mutagene-
sis studies (Sine et al., 1994; Beene et al., 2004). It also suggests a
water-mediatedH-bond between the complementary face and the
agonist hydroxyl, as well as an H-bond between the agonist amine
and TrpB backbone carbonyl (Kesters et al., 2013). Thus, it is only
a few differences that confer on the 5-HT3R its selective recog-
nition of serotonin, including a Loop A glutamate (asparagine in
nAChRs) and a pre-Loop B threonine (lysine inmost nAChRs and
AChBPs; Figure 3), perhaps in combination with a longer Loop C
(Kesters et al., 2013).
CHEMICAL AND STRUCTURAL INSIGHTS INTO AGONIST
RECOGNITION: INHIBITORY RECEPTORS
GABAARs and GlyRs, along with their inhibitory receptor cousins
that are gated by various other agonists, possess TyrB or PheB side
chains in place of the TrpB characteristic of excitatory receptors
(Figure 3), potentially reducing the overall size of the agonist-
binding site so as to optimize it for binding smaller and sterically
less constrained agonists such as glycine and GABA. Nonetheless,
cation-π interactions between the amino groups of glycine or
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GABA have been demonstrated for PheB in the α1 GlyR (Pless
et al., 2008), TyrB in the ρ GABAAR (Lummis et al., 2005) and
PheB in the insect RDL GABA receptor (Lummis et al., 2011). In
MOD-1 (serotonin-gated) and RDL inhibitory receptors, cation-
π interactions involving TrpC2 or TyrC2 (also) occur (Mu et al.,
2003; Lummis et al., 2011). This perhaps reiterates that the struc-
ture of the agonist-binding site and the binding mode of various
agonists are determined not only by ECD amino acid identity but
also by length of loops and the orientation of side chains outside
of the agonist-binding site (Liu et al., 2005; Kehoe et al., 2009;
Xiu et al., 2009). Indeed, Loop A has been proposed as the main
determinant of the different agonist recognition by α and β GlyR
isoforms (Shan et al., 2012), yet their loop A sequences are 100%
identical.
The glutamate-bound C. elegans α GluCl crystal structure
provides the first high-resolution data on an inhibitory, and
indeed on a full-length eukaryotic, Cys-loop receptor (Hibbs and
Gouaux, 2011). It shows that the amine nitrogen of glutamate
interacts with two backbone carbonyls from Loop B (TyrB and
the preceding serine) from its position between three aromatic
side chains, PheA (Phe91), TyrB (Tyr151), and TyrC2 (Tyr200;
there is no C1 aromatic in the GluCl). The functional impor-
tance of the C2 aromatic is evident in reduced responses to
agonists upon the mutation of TyrC2 in the C. elegans β GluCl
(Li et al., 2002; also called GLC-2; Beech et al., 2010), PheC2
in α or TyrC2 in β isoforms of GlyRs (Grudzinska et al., 2005),
TyrC2 in the β isoform of heteromeric GABAARs (Amin and
Weiss, 1993) and TyrC2 in insect RDL GABA receptors (Lummis
et al., 2011). The manner in which this side chain interacts with
the agonist amine differs across receptors, however. In C. elegans
MOD-1 (Mu et al., 2003), in Drosophila RDL (Lummis et al.,
2011) and in GABA recognition by the bacterial ELIC (Spurny
et al., 2012), aromatic C2 forms a cation-π interaction, whereas
in vertebrate GlyRs (Pless et al., 2008) and GABAARs, (Lummis
et al., 2005; Padgett et al., 2007) this is not the case. From
a structural perspective, PheA is positioned similarly to TyrA
(Tyr89) in AChBP (Figure 5), and could serve a similar function
in stabilizing agonist nitrogen atoms, but despite their similar
arrangement in space, inhibitory receptor PheA and excitatory
receptor TyrA differ significantly in two ways: firstly, the pheny-
lalanine at this position in most inhibitory receptor isoforms is
devoid of H-bonding ability, whereas the hydroxyl group of Tyr93
(α), Tyr97 (α4), and Tyr92 (α7) in vertebrate nAChR isoforms
is (also) crucial for acetylcholine recognition (Sine et al., 1994;
Puskar et al., 2011). Secondly, its position in inhibitory receptor
isoforms is actually two positions upstream of that in nAChRs
(Figure 3). This shows that inhibitory and excitatory receptors
have arrived at a similar structural arrangement via different
molecular pathways, highlighting both the importance of X-ray
crystollagraphic studies and the independent evolution of agonist
recognition within the two classes of receptors. Interestingly, the
only inhibitory receptor isoforms to have incorporated an aro-
matic side chain two positions downstream of PheA are the α1-α5
GABAAR isoforms (Figure 3), which contain a histidine in this
location. It is this histidine that determines the high affinity of
benzodiazepines for α1-α5-containing GABAARs (Wieland et al.,
1992).
The above illustrates that the amine of most inhibitory recep-
tor agonists is accommodated by the aromatic box on the
principal face of the ECD, much like excitatory receptor ago-
nists. However, at the complementary face of the agonist-binding
site, the charged carboxyl group of glycine and GABA diverges
considerably from the acetyl, carbamyl, or hydroxyl groups of
acetylcholine, carbamylcholine, and serotonin, respectively. The
α GluCl crystal structure provides a logical explanation for this
difference. The positively charged guanidine side chain of Arg56
in Loop D is within 3 Å of the γ carboxyl of glutamate (Hibbs and
Gouaux, 2011; Figure 4B), suggesting a charge/charge interac-
tion. This LoopD arginine is present in numerous GlyR, GABAAR
and GluCl isoforms (some shown in Figure 3), each of which
contributes the complementary face to the agonist-binding site of
functional receptors (Ffrench-Constant et al., 1993; Cromer et al.,
2002; Bamber et al., 2003; Grudzinska et al., 2005; Goldschen-
Ohm et al., 2011). In vertebrate GABAARs and GlyRs, substi-
tution of this arginine for alanine drastically reduces agonist
sensitivity (Grudzinska et al., 2005; Goldschen-Ohm et al., 2011;
it has not been substituted/tested in GluCls). Notably, this Loop
D arginine is absent from HisCl1, ACC1, MOD-1, and LGC-55,
isoforms that form inhibitory receptors for biogenic amines car-
rying no negative charge. In these isoforms, this Loop D position
is instead occupied by polar amino acids that could foresee-
ably interact with the hydroxyl termini of these agonists directly
or through water molecules, as observed in excitatory recep-
tors. GABAAR β isoforms, which contribute only the principal
face to GABA binding (Cromer et al., 2002), also lack this argi-
nine (Figure 3). The hydroxyl of a Loop C threonine side chain
also appears to interact with the γ carboxyl (Figure 4B), and
mutation of this threonine (Figure 3) to side chains devoid of
hydroxyl groups severely impairs agonist recognition in GlyRs
and GABAARs (Vandenberg et al., 1992; Amin and Weiss, 1993,
1994).
In addition to the γ carboxyl, glutamate also contains an α
carboxyl, constituting a second negative charge on the agonist.
According to the GluCl crystal structure, the latter interacts with
the positively charged side chain of a Loop G arginine (Hibbs
and Gouaux, 2011), whose substitution for alanine in the β
GluCl reduces glutamate sensitivity (Li et al., 2002). (α GluCl
isoforms form homomers that bind glutamate Cheeseman et al.,
2001; Frazier et al., 2013 but are not readily gated by glutamate
alone Cully et al., 1994). This Loop G arginine is absent from
GABAAR and GlyRs (Figure 3) that need only accommodate a
single agonist carboxyl. Thus, the close relation of ECD sequences
in GABAARs, GlyRs, and GluCls, together with structural and
functional data, suggests that inhibitory receptor agonists share
a similar binding mode, with an amine terminal surrounded by
the principal face and a carboxyl terminal interacting with the
complementary face.
OTHER NOTABLE AGONISTS
The description of agonist binding has so far focused on a
handful of endogenous transmitters, but the binding of numer-
ous other relevant agonists has been studied, some of which
are isoform-selective (and used in dissecting isoform compo-
sition), and some of which are potent neurotoxins or widely
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used pharmaceuticals. Nicotine activates nAChRs more potently
than acetylcholine itself (Chavez-Noriega et al., 1997), and its
activation of these receptors stimulates reward pathways in the
brain (Salminen et al., 1999) and up-regulates nAChR expres-
sion (Sallette et al., 2005). The crystal structure of nicotine-bound
AChBP shows nicotine in a similar position to carbamylcholine
(Celie et al., 2004), with the pyrrolidine coordinated by princi-
pal face aromatic side chains and the pyridine oriented toward
the complementary face (Figure 6A). Several nicotine-like com-
pounds are utilized as inseciticides (Millar and Denholm, 2007),
because they activate insect nAChRs more potently than ver-
tebrate nAChRs (Tomizawa and Casida, 2005). Binding of the
canonical neonicotinoid, imidacloprid, has been illustrated by
X-ray crystallography (Ihara et al., 2008; Talley et al., 2008),
and reminiscent of nicotine, the imidazole nitrogens are sur-
rounded by the aromatic box, and the chloropyridine “tail” points
toward Loop E (Figure 6B). The additional nitramide tail, point-
ing toward a LoopD glutamine in AChBP, likely contributes to the
selectivity of imidacloprid for insect nAChRs, as mutation of this
glutamine in the chick α7 nAChR to the arginine present in insect
α nAChR isoforms increases imidacloprid potency (Shimomura
et al., 2002). In a curious parallel with inhibitory receptors,
the imdacloprid nitramide/Loop D arginine interaction of insect
acetylcholine receptors thus structurally reflects the glutamate
carboxyl/Loop D arginine interaction at Loop D of inhibitory
receptors (compare Figures 5B, 6B; AChBP Gln55 corresponds
to α GluCl Arg56). Decreased imidacloprid-sensitivity in a natu-
rally occurring Tyr151Ser mutation in a planthopper nAChR (Liu
et al., 2005) provides another example of allosteric control of the
agonist-binding site, as this side chain (histidine in L. stagnalis
AChBP) is two positions downstream of TrpB and oriented well
away from the bound imidacloprid molecule (Ihara et al., 2008;
Talley et al., 2008).
Several nAChR agonists are also lethal to roundworms, exem-
plified by the well-established anthelmintics levamisole and
pyrantel (Austin et al., 1966; Thienpont et al., 1966) and the
novel anthelmintic monepantel (Kaminsky et al., 2008), which
each act on roundworm nAChRs in a similar manner as the
endogenous agonist acetylcholine (Harrow and Gration, 1985;
Robertson et al., 1994; Rufener et al., 2010). The diversity and
stoichiometry of nematode acetylcholine receptor isoforms (few
of which can truly be referred to as “nicotinic”) is substantial,
and the exact make-up of the native binding sites for these ago-
nists remains enigmatic (Martin et al., 2012). Such sites have not
been probed by mutagenesis or structural methods, but altered
agonist selectivity upon selective over-expression of particular
isoforms may provide some hints as to the molecular determi-
nants of agonist recognition (Ballivet et al., 1996; Raymond et al.,
2000; Williamson et al., 2009; Boulin et al., 2011). Notably, the
levamisole sensitivity of UNC-29 and UNC-38 nAChR isoforms
seems to depend on a glutamate side chain at the position four
downstream from TrpB (Rayes et al., 2004), perhaps indicating
that, like other agonists, levamisole recognition is sensitive to
Loop B-Loop C interactions.
Given the region-specific and behavior-specific expression of
GABAARs in the brain (Rudolph et al., 1999; Low et al., 2000)
and the potency with which GABAAR agonists depress neuronal
function (Krogsgaard-Larsen and Falch, 1981), much effort has
been dedicated to the development of subtype-selective GABAAR
agonists. The structural analogy these compounds share with
GABA, together withmutagenesis data, suggest that themolecular
determinants of recognition are similar to those outlined above
for GABA (Abdel-Halim et al., 2008). Certain agonists, such as
muscimol and 4,5,6,7-tetrahydoisoxazolo[5,4-c]pyridin-3(2H)-
one (THIP), show some subtype-selectivity (Petersen et al., 2013),
possibly due to the differential influence of these agonists on
subsequent conformational changes in different isoform com-
binations (Mortensen et al., 2010). This in turn might be a
consequence of slightly different binding modes from GABA, as
muscimol and THIP possess hydroxyl termini in place of the
carboxyl of GABA, perhaps allowing H-bonds with and water
bridges to the complementary face (Bergmann et al., 2013), as
opposed to the charge/charge interactions proposed for GABA.
RECURRING THEMES OF AGONIST RECOGNITION IN
CYS-LOOP RECEPTORS AND FUTURE CHALLENGES
The preceding sections have highlighted a few principles that
are common to the family: many—if not all—receptors form a
strong cation-π interaction between an aromatic side chain in the
binding site and the agonist protonated amine (or ammonium);
FIGURE 6 | X-ray crystallographic structures of other notable
agonists. (A) L. stagnalis AChBP in complex with nicotine (PDB entry
1UW6). (B) L. stagnalis AChBP in complex with imidacloprid (PDB entry
2ZJU). A red sphere illustrates the oxygen atom of a water molecule
that bridges agonist pyridines to backbone Leu102 carbonyl and Met114
amide groups. In each illustration, numerous segments have been
removed for clarity, including Loop C, of which only selected side
chains are visible.
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for agonists with one or more carboxyl groups, the negative
charge is likely accommodated by charge/charge interactions with
one or more arginine side chains; and in the case of recep-
tors for biogenic amines, which lack a negative charge, the latter
interaction appears to be compensated by H-bonds. The strik-
ing reliance of Cys-loop receptors on cation-π interactions with
agonists raises the question of why this interaction is preferred
over charge/charge interactions (such as those predicted for the
carboxyl groups). We propose the following reasons for this
observation. First, the cation-π interaction is energetically less
dependent on the surrounding dielectric environment (Gallivan
and Dougherty, 2000), which is crucial given that the latter
changes dramatically during the agonist-induced closure of the
binding pocket (Wagner and Czajkowski, 2001; Hansen et al.,
2005; Sharkey and Czajkowski, 2008; Pless and Lynch, 2009;
Sauguet et al., 2014); Lys, Asp and Glu side chains, on the other
hand, can undergo drastic changes in their protonation state
depending on the dielectric environment (Isom et al., 2008).
Furthermore, and unlike charge/charge interactions, the cation-
π interaction requires stringent geometrical constraints and can
only occur within a narrow window of angles of an en face inter-
action between the π electron cloud and a cation (Gallivan and
Dougherty, 1999). This may help to increase selectivity and fur-
ther aid the precise orientation of the agonist in the binding site.
On the one hand, it is hard to conceive how the related receptor
subtypes could have developed such high specificity for different
agonists. On the other, the findings summarized in this review
show that agonist recognition in Cys-loop receptors requires a
complex molecular orchestration of side chains, backbone car-
bonyls, and waters—both inside and outside the actual binding
site. Finally, the wide array of possibilities regarding distinct
subunit interfaces (and thus distinct binding pockets) further
contributes to the diversity and complexity of agonist recognition
in this receptor family.
Despite the intense research that has focused on these receptors
for decades, crucial questions remain as to the precise role of some
of the loop structures in agonist-recognition. For example, Loop
F plays a direct role in agonist recognition according to studies
on nAChRs and 5HT3Rs, and heteromeric GABAARs (Corringer
et al., 1995; Newell and Czajkowski, 2003; Thompson et al.,
2006), but not according to ρ-type GABAAR studies (Sedelnikova
et al., 2005; Khatri et al., 2009). As mutations at different posi-
tions in Loop F preferentially affect agonist affinity in different
states of the activation process, Loop F-agonist interactions prob-
ably change substantially during ligand-induced activation (Sine
et al., 2002), and this is not yet explicable by available struc-
tural data. Further, and despite some recent progress (reviewed
in Nys et al., 2013), our understanding of which molecular deter-
minants discriminate between full and partial agonists is largely
unexplored. However, a better understanding of these factors will
be essential to fully understand ligand recognition and gating in
Cys-loop receptors. Finally, a spectacular example demonstrating
how much there is still to be learnt about even basic principles of
agonist recognition in Cys-loop receptors was recently published
by Stornaiuolo et al. (2013). Their study demonstrated that the
canonical acetylcholine-binding site of AChBP can accommodate
three copies of an aromatic small molecule in an ordered π-π
stack (three identical molecules per binding site), a rare exam-
ple of supramolecular binding at a canonical binding site. These
and other studies will no doubt continue to expand our knowl-
edge about how these therapeutically relevant receptors recognize
and bind their agonists.
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